The Federal Supply Schedule contract is awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency of the U.S. federal government. The contract, valued up to $1,155,030.00, has an ultimate completion date of August 31, 2029 and was awarded to Soleva Pharma LLC, a for-profit limited liability company, on September 1, 2024. The contract is for the procurement of 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS for VISN 12. As a Federal Supply Schedule...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to ITF Therapeutics LLC, a foreign-owned, self-certified small disadvantaged business. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through May 14, 2025. As a Federal Supply Schedule contract, this is a multiple award vehicle...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency, to Valinor Pharma, LLC, a for-profit limited liability company. The contract is a multiple award, non-set-aside agreement with a ceiling value of $25,000.00 and a period of performance through October 17, 2023. The contract is an "Interim Agreement" issued under Federal Supply Schedule 65 I B, which covers Drugs, Pharmaceuticals, & Hematology Related...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, is for the procurement of drugs, pharmaceuticals, and hematology-related products. The prime contractor is Validus Pharmaceuticals, LLC, a for-profit limited liability company that manufactures goods. The contract has a ceiling value of $2,420,310.00 and a period of performance from April 1, 2023 to March 31, 2028. As a Federal Supply Schedule contract, it is a...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs, Veterans Integrated Service Network 12, to Aquestive Therapeutics, Inc., a for-profit manufacturer of goods and subchapter S corporation. The contract, which has a maximum value of $25,000.00 and a period of performance through March 31, 2025, provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract is a multiple...
This Federal Supply Schedule contract award, with a ceiling value of $48,300,000.00, was made by the Veterans Integrated Service Network 12 (VISN 12) to Tersera Therapeutics LLC, a for-profit limited liability company manufacturer of goods. The contract, which has a period of performance ending on March 14, 2029, is for the delivery of Drugs, Pharmaceuticals, & Hematology Related Products under the 65 I B Federal Supply Schedule category. As a multiple award Federal Supply Schedule contract,...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian U.S. federal agency, to Spectrum Pharmaceuticals, Inc., a for-profit manufacturer. The contract, with a ceiling value of $25,000.00, is for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B of the Federal Supply Schedule. The contract period of performance extends from the award date of December 16, 2022 to the ultimate completion...
The Federal Supply Schedule contract 36F79721D0183 was awarded by the Veterans Integrated Service Network 12 (VISN 12) to Akebia Therapeutics, Inc., a for-profit manufacturer, to provide pharmaceuticals and drugs under the FSS-61-IB Pharmaceuticals and Drugs Master Schedule. This multiple-award contract has a total ceiling value of $40,190,500.00 and a period of performance through June 30, 2026. The contract aims to procure a range of pharmaceutical and hematology-related products to support...
This Federal Supply Schedule contract, awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian federal agency, to Long Grove Pharmaceuticals, LLC, provides for the delivery of drugs, pharmaceuticals, and hematology-related products over a period of approximately 5 years, from April 1, 2023 to March 31, 2028. The contract has a ceiling value of $2,072,700.00 and is a multiple award vehicle, meaning multiple contractors may be awarded the opportunity to provide these products...
This Federal Supply Schedule contract was awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 12 to Springworks Therapeutics, Inc. The contract is for INTERIM AGREEMENT UNDER FSS SCHEDULE 65 I B DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, with a ceiling value of $25,000.00 and a period of performance through April 14, 2024. As a Federal Supply Schedule contract, this is a multiple award vehicle that allows government agencies to procure these...